NL7300313A - - Google Patents

Info

Publication number
NL7300313A
NL7300313A NL7300313A NL7300313A NL7300313A NL 7300313 A NL7300313 A NL 7300313A NL 7300313 A NL7300313 A NL 7300313A NL 7300313 A NL7300313 A NL 7300313A NL 7300313 A NL7300313 A NL 7300313A
Authority
NL
Netherlands
Application number
NL7300313A
Other versions
NL179287B (nl
NL179287C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7300313A publication Critical patent/NL7300313A/xx
Publication of NL179287B publication Critical patent/NL179287B/xx
Application granted granted Critical
Publication of NL179287C publication Critical patent/NL179287C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7300313,A 1972-01-12 1973-01-10 Werkwijze voor het bereiden van steroiden van de pregnaanreeks, werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel. NL179287C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB153472A GB1416427A (en) 1972-01-12 1972-01-12 Alkylated pregnanes and process for obtaining same

Publications (3)

Publication Number Publication Date
NL7300313A true NL7300313A (fr) 1973-07-16
NL179287B NL179287B (nl) 1986-03-17
NL179287C NL179287C (nl) 1986-08-18

Family

ID=9723658

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7300313,A NL179287C (nl) 1972-01-12 1973-01-10 Werkwijze voor het bereiden van steroiden van de pregnaanreeks, werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel.
NL930031C NL930031I1 (nl) 1972-01-12 1993-04-28 Werkwijze voor het bereiden van steroïden van de pregnaanreeks werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL930031C NL930031I1 (nl) 1972-01-12 1993-04-28 Werkwijze voor het bereiden van steroïden van de pregnaanreeks werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel

Country Status (17)

Country Link
US (1) US3862194A (fr)
JP (1) JPS5614678B2 (fr)
AT (1) AT367068B (fr)
BE (1) BE793958A (fr)
CA (1) CA1022158A (fr)
CH (1) CH615934A5 (fr)
DE (1) DE2301317C2 (fr)
DK (1) DK139031B (fr)
FI (1) FI52587C (fr)
FR (1) FR2168006B1 (fr)
GB (1) GB1416427A (fr)
HU (1) HU167205B (fr)
IE (1) IE37048B1 (fr)
IL (1) IL41160A (fr)
NL (2) NL179287C (fr)
PH (1) PH9719A (fr)
SE (1) SE411213B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947478A (en) * 1972-01-12 1976-03-30 Akzona Incorporated Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
US4031075A (en) * 1973-07-11 1977-06-21 Akzona Incorporated Alkylated pregnanes and process for obtaining same
GB1478968A (en) * 1973-07-11 1977-07-06 Akzo Nv Alkylated pregnanes
JPS5264666A (en) * 1975-11-25 1977-05-28 Sharp Kk Bothhside circuit substrate
DE3064460D1 (en) * 1979-01-24 1983-09-08 Akzo Nv Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same
JPS58194A (ja) * 1981-06-25 1983-01-05 北陸電気工業株式会社 Ｃｕ粉末導電塗料を用いた印刷抵抗回路基板の製造方法
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
AU7556291A (en) * 1990-03-27 1991-10-21 Schering Corporation Process for 9alpha-hydroxy steroid dehydration
AU1331097A (en) * 1995-12-20 1997-07-14 Schering Corporation Process for preparation of 9,11beta-epoxide steroids
US6040468A (en) * 1996-10-25 2000-03-21 Alcon Laboratories, Inc. Method of preparing 16α, 17α-dialkylated steroids
JP2000502370A (ja) * 1996-10-25 2000-02-29 アルコン ラボラトリーズ，インコーポレイテッド ２１―アルキル化プレグナ−１，４，１６―トリエン―３，２０―ジオンを調製する方法
CN1336824A (zh) * 1997-06-04 2002-02-20 阿克佐诺贝尔公司 抗炎甾类化合物在治疗慢性感染性肠道疾病中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064017A (en) * 1962-11-13 Preparation viii
US3047594A (en) * 1960-05-11 1962-07-31 Pfizer & Co C Preparation of 21-methyl steroids and intermediates
US3114750A (en) * 1960-11-07 1963-12-17 British Drug Houses Ltd 3-enol ethers of 6-formyl-3-oxo-delta4-steroids and process for their preparation
US3166551A (en) * 1962-01-02 1965-01-19 British Drug Houses Ltd Process for the preparation of 3-oxo-delta4-6-methyl steroids
DE1167829B (de) * 1962-08-03 1964-04-16 Schering Ag Verfahren zur Herstellung von 21-Methyl-í¸-pregnen-11ª‰, 17ª‡-diol-3, 20-dion
US3594407A (en) * 1969-04-03 1971-07-20 American Home Prod 13,17-dialkyl-19-norpregn-4-ene,3,20-diones

Also Published As

Publication number Publication date
IL41160A0 (en) 1973-02-28
ATA28373A (de) 1981-10-15
IE37048B1 (en) 1977-04-27
CA1022158A (en) 1977-12-06
FR2168006B1 (fr) 1976-09-03
IE37048L (en) 1973-07-12
FI52587B (fr) 1977-06-30
NL179287B (nl) 1986-03-17
GB1416427A (en) 1975-12-03
NL930031I1 (nl) 1993-07-01
JPS504060A (fr) 1975-01-16
IL41160A (en) 1977-04-29
SE411213B (sv) 1979-12-10
CH615934A5 (fr) 1980-02-29
DE2301317C2 (de) 1983-11-03
FI52587C (fi) 1977-10-10
NL179287C (nl) 1986-08-18
BE793958A (fr) 1973-07-12
PH9719A (en) 1976-02-27
DK139031C (fr) 1979-05-14
DK139031B (da) 1978-12-04
HU167205B (fr) 1975-09-27
US3862194A (en) 1975-01-21
FR2168006A1 (fr) 1973-08-24
JPS5614678B2 (fr) 1981-04-06
DE2301317A1 (de) 1973-07-26
AT367068B (de) 1982-05-25

Similar Documents

Publication Publication Date Title
CS164238B2 (fr)
JPS504621Y2 (fr)
CS158596B2 (fr)
CS170465B2 (fr)
JPS4999387U (fr)
CS164090B1 (fr)
CS170930B1 (fr)
CS172415B1 (fr)
CS170361B1 (fr)
CS169839B2 (fr)
CS172488B1 (fr)
CS170855B1 (fr)
JPS4999766U (fr)
CS159051B1 (fr)
CS159110B1 (fr)
CS162969B1 (fr)
CS171364B1 (fr)
CS158470B1 (fr)
CS152940B1 (fr)
CH564104A5 (fr)
CH574065A5 (fr)
CH574595A5 (fr)
CH574743A5 (fr)
CH574981A5 (fr)
CH575177A5 (fr)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent
AC1 Application for a supplementary protection certificate

Free format text: 930031, 930428

AC1 Application for a supplementary protection certificate

Free format text: 930031, 930428

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 930031